www.fdanews.com/articles/191583-fda-approves-at-home-administration-of-gsk-asthma-drug
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
FDA Approves At-Home Administration of GSK Asthma Drug
June 7, 2019
The FDA has approved an auto-injector and a prefilled syringe for administering GlaxoSmithKline’s respiratory drug Nucala (mepolizumab) at home.
The approval makes GSK’s severe asthma treatment the first anti-IL5 biologic to receive the FDA’s greenlight for at-home administration and the first respiratory biologic that’s received U.S. approval for auto-injector administration.
The drug’s new at-home administration options will be rolled out quickly in the US, the drugmaker said.